Tauroursodeoxycholic Acid Reduces Arterial Stiffness and Improves Endothelial Dysfunction in Type 2 Diabetic Mice

Journal of Vascular Research

Volumn 54, Issue 5, 2017, Pages 280-287

  Battson, Micah L ^a   Lee, Dustin M ^a   Jarrell, Dillon K ^a   Hou, Shoufei ^a   Ecton, Kayl E ^a   Phan, Anna B ^a   Gentile, Christopher L ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

Aortic pulse wave velocity; Arterial stiffness; Endoplasmic reticulum stress; Endothelial function; Perivascular adipose tissue; Tauroursodeoxycholic acid

Indexed keywords

TAUROURSODEOXYCHOLIC ACID; TAUROCHENODEOXYCHOLIC ACID; VASODILATOR AGENT;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL STIFFNESS; ARTICLE; CAROTID ARTERY; CLINICAL EFFECTIVENESS; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; ENDOTHELIAL DYSFUNCTION; MALE; MESENTERIC ARTERY; MOUSE; MYOGRAPHY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PULSE WAVE; REAL TIME POLYMERASE CHAIN REACTION; TREATMENT DURATION; ANIMAL; C57BL MOUSE; COMPLICATION; DIABETIC ANGIOPATHIES; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; PATHOPHYSIOLOGY; VASCULAR ENDOTHELIUM; VASODILATATION;

ANIMALS; CAROTID ARTERIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOPLASMIC RETICULUM STRESS; ENDOTHELIUM, VASCULAR; MALE; MESENTERIC ARTERIES; MICE, INBRED C57BL; MYOGRAPHY; PULSE WAVE ANALYSIS; TAUROCHENODEOXYCHOLIC ACID; VASCULAR STIFFNESS; VASODILATION; VASODILATOR AGENTS;

EID: 85029766205     PISSN: 10181172     EISSN: 14230135     Source Type: Journal    
DOI: 10.1159/000479967     Document Type: Article

References (30)

1. Selvin E, Parrinello CM, Sacks DB, Coresh J: Trends in prevalence and control of diabetes in the United States, 1988-1994 and 1999-2010. Ann Intern Med 2014; 160: 517-525.
2. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339: 229-234.
3. Lorber D: Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus. Diabetes Metab Syndr Obes 2014; 7: 169-183.
4. Widlansky ME, Gokce N, Keaney JF Jr, Vita JA: The clinical implications of endothelial dysfunction. J Am Coll Cardiol 2003; 42: 1149-1160.
5. Woodman RJ, Chew GT, Watts GF: Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy. Drugs 2005; 65: 31-74.
6. Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG: Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation 2002; 106: 2085-2090.
7. Cao SS, Kaufman RJ: Endoplasmic reticulum stress and oxidative stress in cell fate decision and human disease. Antioxid Redox Signal 2014; 21: 396-413.
8. Gentile CL, Pagliassotti MJ: The endoplasmic reticulum as a potential therapeutic target in nonalcoholic fatty liver disease. Curr Opin Invest Drugs 2008; 9: 1084-1088.
9. Ozcan U, Cao Q, Yilmaz E, Lee AH, Iwakoshi NN, Ozdelen E, et al: Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 2004; 306: 457-461.
10. Ozcan U, Yilmaz E, Ozcan L, Furuhashi M, Vaillancourt E, Smith RO, et al: Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 2006; 313: 1137-1140.
11. Pfaffenbach KT, Gentile CL, Nivala AM, Wang D, Wei Y, Pagliassotti MJ: Linking endoplasmic reticulum stress to cell death in hepatocytes: roles of C/EBP homologous protein and chemical chaperones in palmitatemediated cell death. Am J Physiol Endocrinol Metab 2010; 298:E1027-E1035.
12. Ait Aissa K, Trebak M, Belmadani S, Matrougui K: Role of endoplasmic reticulum stress and thrombosis in type 2 diabetes-induced vascular dysfunction. FASEB J 2015; 29:S636. 4.
13. Amin A, Choi SK, Galan M, Kassan M, Partyka M, Kadowitz P, et al: Chronic inhibition of endoplasmic reticulum stress and inflammation prevents ischaemia-induced vascular pathology in type II diabetic mice. J Pathol 2012; 227: 165-174.
14. Sindler AL, Cox-York K, Reese L, Bryan NS, Seals DR, Gentile CL: Oral nitrite therapy improves vascular function in diabetic mice. Diabetes Vasc Dis Res 2015; 12: 221-224.
15. Hotamisligil GS: Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 2010; 140: 900-917.
16. Kaplon RE, Chung E, Reese L, Cox-York K, Seals DR, Gentile CL: Activation of the unfolded protein response in vascular endothelial cells of nondiabetic obese adults. J Clin Endocrinol Metab 2013; 98:E1505-E1509.
17. Cheang WS, Tian XY, Wong WT, Lau CW, Lee SS, Chen ZY, et al: Metformin protects endothelial function in diet-induced obese mice by inhibition of endoplasmic reticulum stress through 5 adenosine monophosphateactivated protein kinase-peroxisome proliferator-activated receptor delta pathway. Arterioscler Thromb Vasc Biol 2014; 34: 830-836.
18. Choi SK, Lim M, Yeon SI, Lee YH: Inhibition of endoplasmic reticulum stress improves coronary artery function in type 2 diabetic mice. Exp Physiol 2016; 101: 768-777.
19. Li Volti G, Salomone S, Sorrenti V, Mangiameli A, Urso V, Siarkos I, et al: Effect of silibinin on endothelial dysfunction and ADMA levels in obese diabetic mice. Cardiovasc Diabetol 2011; 10: 62.
20. Briones AM, Nguyen Dinh Cat A, Callera GE, Yogi A, Burger D, He Y, et al: Adipocytes produce aldosterone through calcineurin-dependent signaling pathways: implications in diabetes mellitus-associated obesity and vascular dysfunction. Hypertension 2012; 59: 1069-1078.
21. Katz PS, Trask AJ, Souza-Smith FM, Hutchinson KR, Galantowicz ML, Lord KC, et al: Coronary arterioles in type 2 diabetic (db/db) mice undergo a distinct pattern of remodeling associated with decreased vessel stiffness. Basic Res Cardiol 2011; 106: 1123-1134.
22. Reil JC, Hohl M, Reil GH, Granzier HL, Kratz MT, Kazakov A, et al: Heart rate reduction by If-inhibition improves vascular stiffness and left ventricular systolic and diastolic function in a mouse model of heart failure with preserved ejection fraction. Eur Heart J 2013; 34: 2839-2849.
23. Wang H, Luo W, Wang J, Guo C, Wang X, Wolffe SL, et al: Obesity-induced endothelial dysfunction is prevented by deficiency of Pselectin glycoprotein ligand-1. Diabetes 2012; 61: 3219-3227.
24. Lee DM, Battson ML, Jarrell DK, Cox-York K, Foster MT, Weir TL, et al: Fuzhuan tea reverses arterial stiffening after modest weight gain in mice. Nutrition 2017; 33: 266-270.
25. Fleenor BS, Eng JS, Sindler AL, Pham BT, Kloor JD, Seals DR: Superoxide signaling in perivascular adipose tissue promotes age-related artery stiffness. Aging Cell 2014; 13: 576-578.
26. Du B, Ouyang A, Eng JS, Fleenor BS: Aortic perivascular adipose-derived interleukin-6 contributes to arterial stiffness in low-density lipoprotein receptor deficient mice. Am J Physiol Heart Circ Physiol 2015; 308:H1382-H1390.
27. Hirota M, Kitagaki M, Itagaki H, Aiba S: Quantitative measurement of spliced XBP1 mRNA as an indicator of endoplasmic reticulum stress. J Toxicol Sci 2006; 31: 149-156.
28. van Schadewijk A, van't Wout EF, Stolk J, Hiemstra PS: A quantitative method for detection of spliced X-box binding protein-1 (XBP1) mRNA as a measure of endoplasmic reticulum (ER) stress. Cell Stress Chaperones 2012; 17: 275-279.
29. Lindstrom P: The physiology of obese-hyperglycemic mice (ob/ob mice). ScientificWorld-Journal 2007; 7: 666-685.
30. Franconi F, Seghieri G, Canu S, Straface E, Campesi I, Malorni W: Are the available experimental models of type 2 diabetes appropriate for a gender perspective? Pharmacol Res 2008; 57: 6-18.